Metallodrugs are unique: opportunities and challenges of discovery and development.

Anthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C, Lant EC, Lermyte F, Needham RJ, Palau M, Sadler PJ, Shi H, Wang FX, Zhang WY, Zhang Z. · 2020

Read Metallodrugs are unique: opportunities and challenges of discovery and development. by Anthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C, Lant EC, Lermyte F, Needham RJ, Palau M, Sadler PJ, Shi H, Wang FX, Zhang WY, Zhang Z. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8163330.txt.

Description

Anthony and co-authors argue that metallodrugs are a class apart in drug discovery. Metals bring chemical traits that pure organic compounds cannot offer. At least 10 metals are essential for human life.

About 46 other metals also serve in drugs and diagnostic agents. Platinum drugs feature in half of cancer chemotherapies. Lithium, silver, and bismuth each fill known roles. The authors show why pipelines built for organic drugs fit metal drugs poorly. They map chances and hurdles in finding and testing new metallodrugs. The field needs its own screening habits, they argue.

Catalog record

CREATORAnthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C, Lant EC, Lermyte F, Needham RJ, Palau M, Sadler PJ, Shi H, Wang FX, Zhang WY, Zhang Z.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE146 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8163330

Browse the full library · About the Tower of Babel